What question did this study set out to answer?

The analysis aims to evaluate the effectiveness of OM-85 in reducing asthma exacerbations in patients with T2-high asthma.

February 9, 2026Open Access

View Full Paper

The bacterial lysate OM-85 Reduces Exacerbations and Oral Corticosteroid Use in Frequently Exacerbating Patients with T2-High Asthma: The OMREXA Real-World Evidence Study

MCMaria Elpida CristopoulouUniversity Medical Center Freiburg LPLilia PanteliAsthma and Allergy Specialists JMJohn MoisidisAsthma and Allergy Specialists

Key Points

The analysis aims to evaluate the effectiveness of OM-85 in reducing asthma exacerbations in patients with T2-high asthma.
Post hoc analysis of real-world evidence data
Focus on frequently exacerbating patients with T2-high asthma
Comparison of exacerbation rates before and after OM-85 administration
Significant reduction in asthma exacerbations noted
Decreased reliance on oral corticosteroids observed
Support for OM-85 as a therapeutic option for T2-high asthma

Abstract

This secondary post hoc analysis supports the therapeutic benefit of OM-85 in patients with T2-high asthma who have frequent exacerbations despite adherence to SoC asthma therapy.

AIに質問

Bookmark

View Full Paper

AIに質問

Bookmark

View Full Paper

The bacterial lysate OM-85 Reduces Exacerbations and Oral Corticosteroid Use in Frequently Exacerbating Patients with T2-High Asthma: The OMREXA Real-World Evidence Study

Key Points

Abstract

Cite This Study

Also Consider

Also Consider